Listed below are the current guidelines, provisional clinical opinions, endorsements, and updates in development. Topics prioritized for development by the Clinical Practice Guidelines Committee and Guideline Advisory Groups are listed by disease site. To submit a topic for consideration, take our survey. To learn more about the ASCO Guideline development process, access the Guideline Methodology page.

Guidelines/Provisional Clinical Opinions (PCOs)/Endorsements in Development

Breast Cancer

Gastrointestinal Cancer

Genitourinary Cancer

Gynecologic Cancer

  • Germline and Somatic Tumor Testing in Ovarian Cancer
  • PARP Inhibitors for Ovarian Cancer

Head and Neck Cancer

  • Unknown Primary in Head and Neck Cancer
  • De-escalation Protocols in the Management of p16+ Orophayngeal Cancer

Hematologic Malignancies

  • Treatment of Multiple Myeloma

Melanoma

  • Systemic Therapy for Melanoma

Neurooncology

  • Treatment of Brain Metastases
  • Management of Glioma
  • Endorsement: Anticonvulsant and Steriod Use in Adults With Metastatic Brain Tumors

Resource Stratified

  • Treatment for Invasive Colorectal Cancer

Supportive Care

Survivorship

Thoracic

Standards

  • Oral Dispensing Standards

Multi-Site

  • Somatic Genomic Panel Testing for Metastatic Disease

Guideline Priorities 2018-2019

Breast Cancer

Gastrointestinal Cancer

  • Advanced (Metastatic) Colon Cancer
  • Treatment Options for Well-Differentiated Neuroendocrine Tumors
  • Systemic Therapy for Advanced Gastric Cancer
  • Neoadjuvant and Adjuvant Therapy for Rectal Cancer, Including Watchful Waiting

Genitourinary Cancer

  • Special Considerations for Elderly Patients With Genitourinary Cancers
  • Cytoreductive Nephrectomy and Metastasis Directed Therapy and Treatment for Advanced Clear Cell Renal Carcinoma
  • Primary Tumor-Directed and Metastasis-Directed Local Therapy in Metastatic Prostate Cancer
  • Update: Muscle-Invasive and Metastatic Bladder Cancer

Gynecologic Cancer

  • First Platinum-Sensitive Ovarian Cancer Recurrence
  • Chemotherapy for Women With Advanced Stage Ovarian/Primary Peritoneal/Fallopian Tube Cancer Following Upfront Surgical Cytoreduction and Front-Line Maintnenance
  • Fertility Sparing Treatment Options for Reproductive Aged Women With Gynecologic Cancers
  • Update: Neoadjuvant Chemotherapy for Ovarian Cancer

Head and Neck Cancer

  • Management of Salivary Gland Malignancy
  • Management of Locoregionally Recurrent Head and Neck Cancer
  • Use of TORS in the Management of Head and Neck Cancer

Multi-Site

  • Germline Genetic Testing
  • Adjuvant Therapy for Soft-Tissue Sarcoma
  • Management of Untreated Follicular Lymphoma

Resource Stratified

Supportive Care

Survivorship

Thoracic

  • Management of Brain Metastases and Leptomeningeal Metastases in NSCLC Patients and Targeted Therapies in the Management of NSCLC
  • Management for Stage III NSCLC
  • Next Generation Sequencing and Other Mutliplex Testing Platforms in Tissue and Blood for Detection of Oncogenic Drivers in Metastatic NSCLC
  • Management of Oligometastasis and Oligoprogressive Disease

Recently Published Guidelines